CoChat

A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Although drug dependence is common in patients with bipolar disorder, minimal data are available on the treatment of drug dependence in this patient population. The authors previously reported a decreased risk of relapse to cocaine use in a pilot study of citicoline in patients with bipolar disorder and cocaine dependence. The primary aim of the present study was to determine whether citicoline reduces cocaine use in outpatients with bipolar I disorder and current cocaine dependence and active cocaine use. METHOD: A total of 130 outpatients with bipolar I disorder (depressed or mixed mood state) and cocaine dependence received citicoline or placebo add-on therapy for 12 weeks. Results of thrice-weekly urine drug screens were analyzed using a generalized linear mixed model that was fitted to the binary outcome of cocaine-positive screens at each measurement occasion for 12 weeks. Mood was assessed with the Inventory of Depressive Symptomatology-Self Report, the Hamilton Depression Rating Scale, and the Young Mania Rating Scale. RESULTS: In the intent-to-treat sample (N=61 in both groups), significant treatment group and group-by-time effects were observed, whether or not missing urine screens were imputed as cocaine positive. The group effect was greatest early in the study and tended to decline with time. No between-group differences in mood symptoms or side effects were observed. CONCLUSIONS: Citicoline was well tolerated for treatment of cocaine dependence in patients with bipolar disorder. Cocaine use was significantly reduced with citicoline initially, although treatment effects diminished over time, suggesting the need for augmentation strategies to optimize long-term benefit.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2015.14070857

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Research works printed but not linked: 5

  1. Himmelhoch JM, 1986, Psychopharmacol Bull, 22, 613
  2. 10.1037/1064-1297.10.3.276 · doi:10.1037/1064-1297.10.3.276 · Paper page
  3. Fioravanti M, 2005, Cochrane Database Syst Rev, 2, CD000269
  4. Secades JJ, 2006, Methods Find Exp Clin Pharmacol, 28, 1
  5. First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version

Cited by

See all 36

Metadata

Authors
Brown, E. S., Todd, J. P., Hu, L. T., Schmitz, J. M., Carmody, T. J., Nakamura, A., Sunderajan, P., Rush, A. J., Adinoff, B., Bret, M. E., Holmes, T., & Lo, A.
Affiliations
National University of Singapore (SG)
Venue
American Journal of Psychiatry
Published
2015-10-01
Volume
172
Issue
10
Pages
1014-1021
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2157470749
Cited by
36
References
43
Citations by year
2024: 6 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 7 · 2017: 7 · 2016: 3 · 2015: 1
FWCI
4.87
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01DA022460, DA022460)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
citicoline, cocaine dependence, bipolar I disorder, cocaine use reduction, relapse prevention, mood symptoms, treatment tolerance
MeSH terms
Adult, Bipolar Disorder, Cytidine Diphosphate Choline, Double-Blind Method, Female, Humans, Male, Middle Aged, Treatment Outcome, Antimanic Agents, Nootropic Agents, Cocaine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder. https://app.cochat.ai/papers/10.1176/appi.ajp.2015.14070857
The paper
Brown, E. S., Todd, J. P., Hu, L. T., Schmitz, J. M., Carmody, T. J., Nakamura, A., Sunderajan, P., Rush, A. J., Adinoff, B., Bret, M. E., Holmes, T., & Lo, A. (2015). A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2015.14070857

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.